Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

CRISPR Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

The gene editing market is experiencing significant growth, with a projected annual growth rate (CAGR) of 16-18% in the coming years. This expansion is fueled by breakthroughs in gene-editing ...

Absolutely! Please provide the article for which you'd like an SEO-friendly meta description, and I'll generate one based on your input.

CRISPR technology, a revolutionary tool in genetic engineering, has empowered Lambert's iGEM team to tackle a significant health issue: Lyme disease, which affects nearly half a million Americans ...

The Lambert High School team, consisting of young genetic engineers led by Sean Lee and Avani Karthik, aimed to address a significant issue: the difficulty in diagnosing Lyme disease during its early ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

Cathie Wood aims to identify innovators and invest in them early in their stories. Wood has been regularly adding to her ...

ToolGen Inc. (KOSDAQ: 199800), a leading genome editing company based in Korea, announced today that it has entered into a strategic cross-license agreement with GenEditBio Limited ("GenEditBio"), a ...